Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
Study KCC-SMT-002, is a Phase 1, single-site, open-label, non-randomized, crossover, flexible
dose design study to investigate the pharmacokinetic (PK) and safety comparing the Sofusa™
system with sumatriptan (KC5010) to Imitrex® oral tablets in 17 healthy volunteers.